Media contacts


 

Meghana Sharafudeen
+41 79 711 5554
msharafudeen@gavi.org
 

Meghana Sharafudeen

Laura Shevlin
+ 41 79 529 92 87
lshevlin@gavi.org
 

Laura Shevlin

Cirũ Kariũki
+41 79 913 94 41
ckariuki@gavi.org
 

Cirũ Kariũki

Collins Weru Mwai
+250787836638
cmwai@gavi.org

Collins Weru Mwai

Eunice Kilonzo-Muraya
+41 76 424 85 03
ekilonzo@gavi.org

Eunice Kilonzo-Muraya

Latest news releases

View all releases

A new era dawns for Gavi, as Board underlines strategic shift towards country ownership and increased support for the most vulnerable

Board decisions place country ownership at the heart of a new operating model, reflecting key elements of the Gavi Leap transformation agenda.

Gavi and Global Polio Eradication Initiative Boards convene for second joint session

The Boards of Gavi, the Vaccine Alliance (Gavi) and the Global Polio Eradication Initiative (GPEI) convened to further strengthen collaboration and accelerate progress toward shared goals: reaching zero-dose and under-immunized children with…

Morocco pledges US$ 5 million to Gavi, debuts as a donor to global immunisation efforts

Morocco makes a donation to Gavi, pledging US$ 5 million towards its next strategic period.

Media resources | assets

If you would you like to receive updates from the Gavi media team, or request access to our digital library of high-resolution images and B-roll, please email media@gavi.org.

Facts and figures

GAVI/2017/Guido Dingemans/Mozambique

Gavi progress reports

Credit: Gavi/2013/Evelyn Hockstein

Types of support

Gavi/2017/Juliette Bastin/Burkina Faso

Communication toolkits

Gavi/2024/Jjumba Martin

Country hub

Gavi/2014/GMB Akash

Snap analyses

Gavi/2022/Benedikt v.Loebell

Gavi leadership

José Manuel Barroso
Board Chair

José Manuel Barroso

Dr Sania Nishtar
CEO

Dr Sania Nishtar

Gavi Secretariat
 

Gavi/2025

Opinions

View all opinions

Fragility is on the rise. So is Gavi’s commitment to tackling it

Despite a $3 billion shortfall in funding over the next five years, Gavi will increase its support for populations in fragile and humanitarian settings. As CEO Sania Nishtar explains, Gavi will continue to protect the world's most vulnerable…

New vaccines could help us consign tuberculosis to history: here’s how we can do it

New tuberculosis vaccine candidates are currently going through the final stages of clinical trials. We need to work together to ensure they reach the millions who need them quickly and effectively.

Three years ago we made a promise to girls around the world to help end the scourge of cervical cancer. Today we have honoured it.

In December 2022 Gavi set an ambitious target of reaching 86 million girls with the HPV vaccine by the end of 2025. We have met it ahead of schedule.

Last updated: 7 May 2025